IMMNOV.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Diagnostics & Research

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$3M	+200.0%	$-0.10	$-0.10–$-0.10	—	1
2027	$17M	+466.7%	$-0.04	$-0.04–$-0.04	—	1
2028	$55M	+223.5%	$-0.02	$-0.02–$-0.02	—	1
2029	$110M	+100.0%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 3 of the last 6 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-06	$-0.04	$-0.04	+0.0%
2026-05-07	$-0.03	$-0.03	+3.5%
2026-02-24	$-0.04	$-0.03	+22.8%
2025-11-26	$-0.05	$-0.08	-66.8%
2025-08-21	$-0.06	$-0.11	-81.4%
2025-05-14	$-0.12	$-0.24	-100.0%

DCF fair valuemodel estimate

Intrinsic value

$0.22

Price

$0.15

Implied upside

+39%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
IMMNOV.STImmunovia AB	$0.15	-5.03%	$52M	—
ACTI.STActive Biotech AB	$3.98	-0.62%	$105M	—
BIOVIC-B.STBiovica International AB (publ)	$0.30	-0.97%	$85M	—
HEART.STScandinavian Real Heart AB (Publ)	$16.95	+0.89%	$144M	—
ICO.STIconovo AB (publ)	$1.23

Immunovia AB

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

www.immunovia.com

Employees: 18
IPO / List date: Dec 1, 2015
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds IMMNOV.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in IMMNOV.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded IMMNOV.ST yet.